Provectus Biopharmaceuticals PVCT 2017 Conference Presentation

Provectus Biopharmaceuticals held an investor conference call on February 9, 2017, presenting company updates and strategic information. The presentation materials were filed with the SEC as part of the company's Form 8-K current report filing.